A Study to Learn About the Safety of Diroximel Fumarate (DRF) and Dimethyl Fumarate (DMF) and Their Effects on Relapses in Pediatric Participants With Relapsing Forms of Multiple Sclerosis (RMS)
Clinical trial NCT07483632 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07483632
- Sponsor
- Biogen
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-11-16
- Primary completion
- 2034-07-28
- Enrollment
- 185
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.